stocksbrew
Pulse
Radar
Pulse
Radar
stocksbrew.

Clear calls on your watchlist. Fundamentals, news, Reddit, and earnings in one read. Set triggers on Radar and get emailed in buy or sell zones. US markets.

Live now

Product

  • Market Pulse
  • Radar
  • Pre-market movers
  • Earnings

Free tools

  • All free tools
  • Should I Buy?
  • Compare stocks
  • Portfolio Analyzer
  • Position calculator
  • Market Heat
  • Screens

Resources

  • Learn & guides
  • Blog
  • Use cases
  • Compare stocksbrew

Company

  • About
  • Pricing
  • Contact
  • Terms of service
  • Privacy policy
  • Cookie policy
  • Disclaimer
Featured on ScrollLaunch

© 2026 stocksbrew. All rights reserved.

stocksbrew provides market data and analytics for informational purposes only. Nothing here is investment advice. Past performance does not guarantee future results.

PF

PFE

Pfizer Inc.

$23.73

▼ -2.43%

−$0.59

NYSE · Healthcare · Drug Manufacturers - General

today's anomaly
PF

Pfizer Inc.

today's anomaly

PFE · NYSE · Healthcare · Drug Manufacturers - General

$23.73

▼ -2.43% · −$0.59 today

where it sits

52-week range
Low$23.11
High$28.75
Today $23.73
RSI (14)
34.5Neutral
03070100

the numbers

P/E (TTM)18.1
Revenue growth+1.4%
EPS next Y-4.5%
Beta0.31
Market cap$135.25B
Revenue$63.31B

financials · ttm

Revenue

$63.31B

Net income

$7.52B

EPS

$1.31

Op. income

$7.91B

Gross profit

$46.55B

Rev growth

+1.4%

fundamentals45 /100 vs peers

weak

Revenue growth (TTM)1.4
91% below Sector 5Y avg avgSector 5Y avg: 14.4
EPS growth (TTM)-5.4
147% below Sector 5Y avg avgSector 5Y avg: 11.6
EPS forecast (5Y)-9.1
163% below Sector fwd avg avgSector fwd avg: 14.5
EPS next year-4.5
weak pace
EPS growth (Q/Q)-9.8
weak pace

Compared against sector peers where available.

vs sector peers

companymkt capP/Erev growthscore
PF
PFEPfizer Inc.
$135.25B18.1+1.4%45
IN
INDVIndivior
$4.85B20.2+10.3%81
GM
GMEDGlobus Medical
$10.87B18.7+23.5%78
DX
DXCMDexcom
$27.49B30.5+16.1%78
LL
LLYEli Lilly and Company
$1.14T43.7+47.4%77

today's move

▼ -2.4%−$0.59

Pfizer faces pipeline and leadership doubts

high

Today's article highlights growing concerns over Pfizer's drug pipeline and uncertainty about its leadership team, casting doubt on future earnings and growth prospects. Such negative sentiment can prompt investors to sell, contributing to the 2.4% price decline.

smart alerts

Recent News

2 stories · last 7 days · PFE

  • Pfizer's Growth Story Faces a Wait as Pipeline and Leadership Doubts Mount - Benzinga

    Bearish3h ago · Benzinga
  • Pfizer (PFE) Wins FDA Approval For IBRANCE In HER2 Positive Breast Cancer

    Bullish7h ago · Pfizer Inc. via Yahoo Finance
all market news→